跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
择思达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Atomoxetine Hydrochloride Oral Solution
Approved
化学药品
Atomoxetine Hydrochloride Oral Solution
LILLY SA
🇨🇳 National Medical Products Administration
Approval Date
Oct 17, 2023
Approval ID
8TEL7S4XWTj
Company
LILLY SA
Type
化学药品
Approval Details
Approval Id
8TEL7S4XWTj
Approval Number
国药准字HJ20180057
Generic Name
盐酸托莫西汀口服溶液
Generic Name En
Atomoxetine Hydrochloride Oral Solution
Brand Name
择思达
Drug Type
化学药品
Dosage Form
口服溶液剂
Strength
100ml:400mg,4mg/mL(按C₁₇H₂₁NO计)
Reg Date
2023-10-17
Expired Date
2028-05-15
Company Name
LILLY SA
Production Company Name
PATHEON FRANCE
Company Detail Path
/organization/lilly-sa
Production Company Detail Path
/organization/patheon-france
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 17, 2023
Approval ID
8TEL7S4XWTj
Type
化学药品
Back to NMPA Approvals